To the full analysis
PolyPeptide Group stock: growth
PPGN.SWPolyPeptide Group reported $434.23M in revenue for fiscal 2025, up 15.7% on the prior year, up 11.8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
11.8%
per year from 2018 to 2025, per share 10.3%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2018 | |
|---|---|---|
| Revenue | 11.8% | 11.8% |
| Revenue per share | 9.7% | 10.3% |
| Earnings | no data | no data |
| Earnings per share | no data | no data |
| Free cash flow | no data | no data |
| Free cash flow per share | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2018 | $198.99M | $26.39M | $5.15M |
| 2019 | $224.52M | $28.52M | $39.78M |
| 2020 | $248.54M | $34.72M | $9.82M |
| 2021 | $312.62M | $52.37M | −$18.4M |
| 2022 | $311.35M | $8.61M | −$77.17M |
| 2023 | $355M | −$57M | −$22.44M |
| 2024 | $375.3M | −$21.68M | $2.69M |
| 2025 | $434.23M | −$23.61M | −$33.73M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CHF 0.8331, $1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Apr 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.